A recent report in the CDC’s Morbidity and Mortality Weekly Report (MMWR) may offer one of the best analyses of an increasing risk for diagnosis with and death from advanced forms of prostate cancer over the period from 2003 to 2017 (the last year for which we have accurate data from the SEER database). … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: CDC, Diagnosis, epidemiology, incidence, mortality, risk | 3 Comments »
The RESPOND study, which was initiated in July last year, appears to be the largest-ever study of risk factors for prostate cancer among the African American community, and probably among Black men worldwide. … READ MORE …
Filed under: Living with Prostate Cancer, Risk | Tagged: African American, epidemiology, research, RESPOND, risk | Leave a comment »
The National Cancer Institute has invested over $20 million in a new study that will attempt to enroll 10,000 African-American men who have been diagnosed with prostate cancer: the RESPOND study. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: African American, environment, epidemiology, genetics, risk | Leave a comment »
As it does every year, the American Cancer Society (ACS) has just published it’s annual update cancer statistics update: Cancer Facts & Figures 2017. Those who are interested are of course welcome to peruse this detailed document for themselves. What follows is a quick summary of the prostate cancer-related data in the ACS update. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: epidemiology, incidence, mortality, risk, survival | 9 Comments »
A recent article in the Journal of Clinical Pathology reviews available data about the epidemiology, biology, and clinical pathology of “young age” prostate cancer, which the authors define as clinically significant cancer in men under 55 years of age. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: age, biology, epidemiology, pathology, risk, young | Leave a comment »
Prior to 2013, when the National Cancer Institute released accumulated, de-identified, prostate cancer-specific patient data from the national SEER cancer registry, those data only included the post-surgical, pathological Gleason scores and not the biopsy Gleason scores. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: Diagnosis, epidemiology, Management, risk, Treatment | Leave a comment »
According to a new study in the American Journal of Epidemiology, a history of working night shifts may be associated with a large increase in risk for prostate cancer. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: epidemiology, night work, risk | 4 Comments »
One of the posters to be presented at the upcoming annual meeting of the American Society of Clinical Oncology offers an interesting model permitting replicative estimation of the numbers of patients living with different clinical stages of prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management | Tagged: clinical status, epidemiology, prevalence, stage | 4 Comments »
The recently announced GLOBOCAN 2008 assessment of the worldwide burden of cancer includes a global estimate of 258,000 deaths from prostate cancer in 2008, and a global incidence of 913,000 cases of prostate cancer that same year. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer | Tagged: epidemiology, incidence, mortality | 8 Comments »
This weekend’s news reports deal with:
Filed under: Drugs in development, Management, Prevention, Treatment | Tagged: epidemiology, hormone therapy, PSA: 154-163 (155L), radiotherapy, zoledronic acid | 5 Comments »
News reports today cover such issues as:
Filed under: Diagnosis, Living with Prostate Cancer, Prevention, Risk | Tagged: cognitive function, epidemiology, estrogen, etiology, genetic testing, heredity, testosterobe, vitamin D | Leave a comment »
A paper just published in the Journal of Clinical Oncology ( and available in full on line) includes data projecting 382,000 new cases of prostate cancer in the USA in 2030. … READ MORE …
Filed under: Diagnosis, Prevention, Risk | Tagged: epidemiology, incidence | 1 Comment »
A discussion has unfolded on the Prostate Cancer InfoLink Caribbean Group forum. It has to do with the high mortality rates relative to incidence.
A question has been raised regarding stage at diagnosis, which, if late, can help to explain the ratio. Does anyone know where we can get good stage-at-diagnosis statistics for the Caribbean?
Click the image on the right to see an enlarged version of the incidence and mortality table.
Filed under: Prevention | Tagged: Arnon Krongrad MD, epidemiology, statistics | 1 Comment »
THE "NEW" PROSTATE CANCER INFOLINK 